Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Whey protein (20 grams), Whey protein (60 grams).
- Кому может быть актуально
- Состояния в реестре: Cancer, Breast Cancer. Базовые параметры: 20 лет — 89 лет · Женщины.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- США
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
NeoChemoPRT: A Randomized Study of Resistance Training and Post-Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
Обзор
In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.
Вмешательства
- Пищевая добавка Whey protein (20 grams)
20 grams of whey protein - Пищевая добавка Whey protein (60 grams)
60 grams of whey protein.
Первичные конечные точки
- Changes in muscle mass and fat mass (pounds) at completion of chemotherapy [Срок оценки: Baseline and at program completion (within 4 weeks of exercise completion).]
Вторичные конечные точки (10)
- Response to Chemotherapy Assed Via the Guidelines or the Response evaluation criteria in solid tumors (RECIST) [Срок оценки: Chemotherapy response assessment is at program completion (within 4 weeks of exercise completion)]
- Changes in EuroQol-5 Dimensions (EQ-5D) at completion of chemotherapy assessment [Срок оценки: Baseline assessment (prior to program) and at exercise program completion (at 24 weeks).]
- Changes in Patient Health Questionnaire-9 (PHQ9) depression score at completion of chemotherapy assessment [Срок оценки: Baseline assessment (prior to program) and at exercise program completion (at 24 weeks).]
- Changes in General Anxiety Disorder-7 (GAD7) anxiety score at completion of chemotherapy assessment [Срок оценки: Baseline assessment (prior to program) and at exercise program completion (at 24 weeks).]
- Changes in activity levels via Godin Leisure-Time Exercise Questionnaire [Срок оценки: Baseline assessment (prior to program) and at exercise program completion (at 24 weeks).]
- Changes in resting metabolic rate at completion of chemotherapy [Срок оценки: Baseline and at program completion (within 4 weeks of exercise completion).]
- Changes in body composition at completion of chemotherapy, including fat-free mass in pounds. [Срок оценки: Baseline and at program completion (within 4 weeks of exercise completion).]
- Changes in Y-Balance Test Scores at baseline and at completion of chemotherapy [Срок оценки: Baseline and at program completion (within 4 weeks of exercise completion).]
- Changes in Functional Mobility Score at baseline and at completion of chemotherapy [Срок оценки: Baseline and at program completion (within 4 weeks of exercise completion).]
- Changes in phase angle at completion of chemotherapy [Срок оценки: At program completion (at 24 weeks)]
Критерии участия
Критерии включения
- Age 20-89 years
- Women with a biopsy proven diagnosis of invasive carcinoma of the breast.
- Women must undergo neoadjuvant chemotherapy for breast cancer treatment prior to surgery
- Must be able to read and understand English and consent for themselves.
Критерии исключения
- Inability to get up and down off the ground or squat body weight
- Inability to safely engage in group exercise sessions as deemed by study PI
- Severe arthritic, joint, cardiovascular, musculoskeletal, or any other condition deemed by PI to be unsafe to engage in resistance training
- Lactose intolerance
- Cow's milk or whey protein allergy
- Pregnant women
- Males
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Простое слепое
- Основная цель
- Другое
Центры проведения
США · 1 центр
- Allegheny General Hospital — Pittsburgh
Идентификаторы
NCT: NCT06858449 · 2024-149-SG